-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Fennec Pharmaceuticals Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2023 to Q2 2024.
- Fennec Pharmaceuticals Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $4.67M, a 99.7% increase year-over-year.
- Fennec Pharmaceuticals Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $17.1M.
- Fennec Pharmaceuticals Inc. annual Selling and Marketing Expense for 2023 was $12.1M, a 335% increase from 2022.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)